Presentations & Talks
Invited talks
Causal Inference & AI for Health Meeting @LDE [Leiden University, TU Delft, Erasmus MC Rotterdam], Leiden (NL), 23/10/2023.
"Investigating positivity violations in marginal structural survival models: a study on estimator IPTW performance"Department of Economics, Business and Statistics, University of Palermo, Palermo (IT), 16/3/2023.
“Causal effects of chemotherapy regimen intensity on survival outcome in osteosarcoma patients through Marginal Structural Cox Models"Health Data Science Special Interest Group @Leiden University, Leiden (NL), 26/1/2023.
“Causal effects of chemotherapy regimen intensity on survival outcome in osteosarcoma patients through Marginal Structural Cox Models"Princess Máxima Center for Pediatric Oncology, Utrecht (NL), 24/1/2023.
“Causal effects of chemotherapy regimen intensity on survival outcome in osteosarcoma patients through Marginal Structural Cox Models"PhD Colloquium @Mathematical Institute, Leiden University, Leiden (NL), 7/6/2022.
“My PhD journey & my research"Health Data Science Special Interest Group @Leiden University, Leiden (NL), 16/12/2021.
“Modelling longitudinal Latent Overall Toxicity (LOTox) profiles in osteosarcoma patients”European Organisation for Research and Treatment of Cancer, Bruxelles (Belgium), 30/11/2021.
“Modelling longitudinal Latent Overall Toxicity (LOTox) profiles in osteosarcoma patients”Statistics Group @Leiden University Medical Center, Leiden (NL), 25/11/2021.
“Modelling longitudinal Latent Overall Toxicity (LOTox) profiles in osteosarcoma patients”Survival Group @Leiden University Medical Center, Leiden (NL), 26/4/2021.
“Modelling longitudinal latent toxicity profiles evolution in osteosarcoma patients”Statistics Group @Mathematical Institute, Leiden University, Leiden (NL), 1/3/2021.
“Modelling longitudinal latent toxicity profiles in osteosarcoma patients”Statistics Group @MOX Laboratory, Politecnico di Milano, Milan (IT), 10/6/2020.
“Including time-varying covariates in time-to-event framework with applications to heart failure and osteosarcoma”QP Group @Leiden Academic Centre for Drug Research, Leiden (NL), 28/5/2020.
“Including dynamic covariates in survival models via Functional Data Analysis”Princess Máxima Center for Pediatric Oncology, Utrecht (NL), 26/5/2020.
“Including dynamic covariates in survival models via Functional Data Analysis”Statistics Group @Mathematical Institute, Leiden University, Leiden (NL), 3/12/2019.
“Including dynamic covariates in survival models via Functional Data Analysis”
Contributed talks
SAfJR 2023 – 9th Survival Analysis for Junior Researchers Conference, Ulm (Germany), 13-15/9/2023.
"Investigating positivity violations in marginal structural survival models: a simulation study"ISCB44 – 44th Annual Conference of the International Society for Clinical Biostatistics, Milan (IT), 27-31/8/2023.
"Investigating positivity violations in marginal structural survival models: a study on estimator performance"IBC 2022 – 31st International Biometric Conference, Riga (Latvia), 10-15/7/2022.
“Causal effects of chemotherapy regimen intensity on survival outcome through Marginal Structural Models”XI National Congress SISMEC (Italian Society of Medical Statistics and Clinical Epidemiology) 2021, Bari (IT), 15-17/9/2021.
“Functional modelling of recurrent drug purchases and re-hospitalizations on survival in Heart Failure patients: a real-world case study"ISCB42 – 42nd Annual Conference of the International Society for Clinical Biostatistics, Lyon (France), 18-22/7/2021.
“Modelling the effect of longitudinal latent toxicity profiles on survival: an application to osteosarcoma”SIS 2021 – 50th Meeting of the Italian Statistical Society, Pisa (IT), 21-25/6/2021.
“Modelling longitudinal latent toxicity profiles evolution in osteosarcoma patients”ISCB41 – 41st Annual Conference of the International Society for Clinical Biostatistics, Krakow (Poland), 23-27/8/2020.
“Including dynamic covariates in survival models via Functional Data Analysis: an application to osteosarcoma”X National Congress SISMEC 2019, Rome (Italy), 18-21/9/2019.
“Impact of time-dependent medication adherence on Heart Failure patients using a Joint Modelling framework”SIS 2019 - Smart Statistics for Smart Applications, Milan (Italy), 18-21/6/2019.
“Joint Models: a smart way to include functional data in healthcare analytics”Joint congress SISMEC & Alessandro Liberati Association, Rome (IT), 7-8/11/2018.
“Target dosages and adherence to PolyPharmacy therapy: a case study based on a regional real-world HF community”
Posters
ISCB43 – 43rd Annual Conference of the International Society for Clinical Biostatistics, Newcastle Upon Tyne (UK), 21-25/8/2022.
“Causal effects of chemotherapy dose intensity on survival outcome through Marginal Structural Models"ISCB40 – 40th Annual Conference of the International Society for Clinical Biostatistics, Leuven (Belgium), 14-18/7/2019.
“Investigating the role of Proteinuria in Renal Disease: a real-world clinical case study”SIS 2018 – 49th Meeting of the Italian Statistical Society, Palermo (IT), 20-22/6/2018.
"Investigating the effect of drugs consumption on survival outcome of Heart Failure patients using joint models: a case study based on regional administrative data"
